Sep 8, 2022 12:01PM

Sep 8, 2022 06:15AM

Sep 7, 2022 07:45PM

Sep 7, 2022 10:02AM

Sep 7, 2022 10:00AM

Sep 2, 2022 12:17PM

Sep 2, 2022 12:15PM Amylyx Pharmaceuticals Announces Posting of Briefing Documents for Second FDA Advisory Committee Meeting on AMX0035

Aug 11, 2022 04:01PM

Aug 3, 2022 09:03AM

Aug 3, 2022 09:00AM

Jul 5, 2022 09:01AM

Jul 5, 2022 09:00AM

Jun 13, 2022 07:00AM

Jun 13, 2022 07:00AM Amylyx Pharmaceuticals Announces Health Canada Approval of ALBRIOZA™ for the Treatment of ALS

Jun 3, 2022 10:30AM

Jun 3, 2022 07:04AM

Jun 3, 2022 07:00AM

May 25, 2022 03:59AM

May 12, 2022 04:01PM

Apr 1, 2022 04:22AM

Mar 31, 2022 06:33AM Amylyx Pharmaceuticals (AMLX) Confirms Outcome of FDA Advisory Committee Meeting on AMX0035 for the Treatment of ALS

Mar 30, 2022 07:33PM

Mar 30, 2022 07:00PM

Mar 30, 2022 07:07AM

Mar 30, 2022 07:00AM

Mar 28, 2022 10:45AM

Feb 25, 2022 08:08AM

Feb 25, 2022 08:00AM Amylyx Pharmaceuticals Announces EMA Validation of Marketing Authorisation Application (MAA) for AMX0035 for the Treatment of ALS

Feb 16, 2022 04:05PM

Feb 1, 2022 04:20AM

15,414 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All